North America Lymphedema Treatment Market Trends and Analysis by 2028
North America Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
- Report Date : Mar 2022
- Report Code : TIPRE00027833
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 131
The lymphedema treatment market in North America is expected to grow from US$ 3,880.04 million in 2021 to US$ 5,419.77 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2021 to 2028.
According to the Cleveland Clinic report, lymphedema can develop when there is damage to the lymphatic system or disruption in lymphatic damage. For example, lymph fluids drain into soft tissues, causing swelling and can occur anywhere in the body, with most cases occurring in arms and legs. Apart from that, cancer surgeries, radiation treatments, and other medical conditions raise the risk of lymphedema among patients. Additionally, among the gynecologic oncologic population, an increase in body mass index, insufficient levels of physical activity, and presence of pre-treatment lymphedema may be witnessed as potentially high-risk factors of lymphedema development. For example, oncological surgical procedures such as sentinel lymph nodes biopsy and radical dissection requiring excision of regional lymph nodes or vessels result in the development of secondary lymphedema. According to one report, lymphedema can occur after any cancer or its treatment affecting lymph node drainage. For example, it has been reported that it can occur within days and up to 30 years after the treatment for breast cancer. Also, 80% of patients experience onset within three years of surgery, and the remainder develops edema at a rate of 1% per year. Additionally, a large patient pool suffers from lower-limb lymphedema, particularly women after treatment for gynecological cancer, with the highest prevalence (36%) among vulvar cancer survivors and lowest prevalence (5%) among ovarian cancer survivors. Further, the overall incidence of arm lymphedema ranges from 8% to 56% at two years post-surgery. Furthermore, lymphedema may and do occur in the trunk, in addition to limbs. For example, radiation therapy to the chest wall is associated with the development of edema, particularly in the irradiated breast. Additionally, the healthcare system requires highly advanced treatment products. Therefore, major players are highly focusing on new and innovative product launches and approvals. Furthermore, with surging volume of lymphedema prevalence fuels the demand for lymphedema treatment ultimately contributing for the overall market growth.The world has watched several viruses such as SARS, H1N1, and others over the past few years. However, the severity of the coronavirus made the condition difficult. Coronavirus disease (COVID-19) is a contagious disease that has been affected by a newly discovered coronavirus. In the North American region, the United States was heavily impacted by the outbreak of the COVID-19 pandemic. The country has had the highest number of positive patients. COVID-19, first discovered in December in Wuhan, China, has made more than 203,456,777 people sick worldwide and killed at least 4.3 million people, according to Worldometer data as of August 9th, 2021. US coronavirus cases are increasing the most in the world. There have been around 36,543,338 confirmed cases of COVID-19 in the United States, with 633,116 deaths. The COVID-19 pandemic has brought about technological changes that are critical to better care. As the number of coronavirus cases climbs in the United States, many aspects of quarantine are becoming semi-permanent, at the very least. The prolonged shut-in situation is devastating news for countless industries impacted by business closures, but there are bright spots for sectors that have thrived amid the global health crisis so far. Lymphedema Treatment is one sector that has showed remarkable stamina. According to Marry Ann Libert, the COVID-19 lockdown had a great impact on lymphedema patients in both medical and psychological aspects across the United States.With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the lymphedema treatment market. The North America lymphedema treatment market is expected to grow at a good CAGR during the forecast period.
North America Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America Lymphedema Treatment Market Segmentation
North America Lymphedema Treatment Market – By Condition Type
- Primary Lymphedema
- Secondary Lymphedema
North America Lymphedema Treatment Market – By Treatment Type
- Laser Therapy
- Compression Devices
- Drug Therapy
- Physiological Procedures
- Lymphovenous Anastomosis (LVA)
- Vascularised Lymph Node Transfer (VLNT)
- Debulking Procedures
- Surgical Debulking
- Liposuction
- Others
- Others
North America Lymphedema Treatment Market – By End-User
- Hospitals
- Clinics
- Clinical Research Organizations
- Others
North America Lymphedema Treatment Market- By Country
- US
- Canada
- Mexico
North America Lymphedema Treatment Market-Companies Mentioned
- 3M Company
- Bio Compression Systems Inc.
- BSN medical GmbH
- Huntleigh Healthcare Limited
- Lohmann & Rauscher GmbH & Co. KG
- Mego Afek ltd
- Sigvaris Group
- Smith & Nephew
- Tactile Medical
- ThermoTek
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Lymphedema Treatment Market – By Condition Type
1.3.2 North America Lymphedema Treatment Market – By Treatment Type
1.3.3 North America Lymphedema Treatment Market – By End-User
1.3.4 North America Lymphedema Treatment Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Lymphedema Treatment Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Lymphedema Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Incidence of Lymphedema Cases
5.1.2 Increasing Healthcare Facilities
5.2 Market Restraints
5.2.1 Lack of Awareness and Skilled Professionals
5.3 Market Opportunities
5.3.1 Rising Treatment Options
5.4 Future Trends
5.4.1 Use of Robotics for Lymphedema Treatment
5.5 Impact Analysis
6. Lymphedema Treatment Market– North America Analysis
6.1 North America Lymphedema Treatment Market Revenue Forecast and Analysis
7. North America Lymphedema Treatment Market– By Condition Type
7.1 Overview
7.2 North America Lymphedema Treatment Market, By Condition Type, 2021 & 2028 (%)
7.3 Primary Lymphedema
7.3.1 Overview
7.3.2 Primary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Secondary Lymphedema
7.4.1 Overview
7.4.2 Secondary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8. North America Lymphedema Treatment Market – By Treatment Type
8.1 Overview
8.2 North America Lymphedema Treatment Market, By Treatment Type, 2021 & 2028 (%)
8.3 Laser Therapy
8.3.1 Overview
8.3.2 Laser Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Compression Devices and Bandaging
8.4.1 Overview
8.4.2 Compression Devices and Bandaging: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Drug Therapy
8.5.1 Overview
8.5.2 Drug Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Physiological Procedures
8.6.1 Overview
8.6.2 Physiological Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.6.2.1 Lymphovenous Anastomosis (LVA)
8.6.2.1.1 Overview
8.6.2.1.2 Lymphovenous Anastomosis (LVA): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.6.2.2 Vascularized Lymph Nodes Transfer (VLNT)
8.6.2.2.1 Overview
8.6.2.2.2 Vascularized Lymph Nodes Transfer (VLNT): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7 Debulking Procedures
8.7.1 Overview
8.7.2 Debulking Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7.2.1 Surgical Debulking
8.7.2.1.1 Overview
8.7.2.1.2 Surgical Debulking: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7.2.2 Liposuction
8.7.2.2.1 Overview
8.7.2.2.2 Liposuction: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7.2.3 Others
8.7.2.3.1 Overview
8.7.2.3.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9. North America Lymphedema Treatment Market – By End User
9.1 Overview
9.2 North America Lymphedema Treatment Market, By End User, 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.5 Clinical Research Organization (CRO’s)
9.5.1 Overview
9.5.2 Clinical Research Organizations (CRO’s): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10. North America Lymphedema Treatment Market – By Country Analysis
10.1 Overview
10.1.1 North America: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)
10.1.1.1 US: Lymphedema Treatment Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 US: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.2 US: Lymphedema Treatment Market, by Condition Type, 2019–2028 (US$ Million)
10.1.1.1.3 US Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3.1 US: Lymphedema Treatment Market, by Physiological Procedures, 2019–2028 (US$ Million)
10.1.1.1.3.2 US: Lymphedema Treatment Market, by Debulking Procedures, 2019–2028 (US$ Million)
10.1.1.1.4 US: Lymphedema Treatment Market, by End User, 2019–2028 (US$ Million)
10.1.1.2 Canada: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Canada: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.2 Canada: Lymphedema Treatment Market, by Condition Type, 2019–2028 (US$ Million)
10.1.1.2.3 Canada: Lymphedema Treatment Market, by Non- Treatment Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 Canada: Lymphedema Treatment Market, by Physiological Procedures, 2019–2028 (US$ Million)
10.1.1.2.3.2 Canada: Lymphedema Treatment Market, by Debulking Procedures, 2019–2028 (US$ Million)
10.1.1.2.4 Canada: Lymphedema Treatment Market, by End User, 2019–2028 (US$ Million)
10.1.1.3 Mexico: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Mexico: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.2 Mexico: Lymphedema Treatment Market, by Condition Type – 2019–2028 (US$ Million)
10.1.1.3.3 Mexico: Lymphedema Treatment Market, by Treatment Type – 2019–2028 (US$ Million)
10.1.1.3.3.1 Mexico: Lymphedema Treatment Market, by Physiological Procedures – 2019–2028 (US$ Million)
10.1.1.3.3.2 Mexico: Lymphedema Treatment Market, by Debulking Procedures, 2019–2028 (US$ Million)
10.1.1.3.4 Mexico: Lymphedema Treatment Market, by End User, 2019–2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on North America Lymphedema Treatment Market
11.1 Overview
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Bio Compression Systems Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Tactile Medical
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Smith & Nephew
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BSN medical GmbH
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Lohmann & Rauscher GmbH & Co. KG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Sigvaris Group
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 ThermoTek
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Huntleigh Healthcare Limited
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 3M Company
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Mego Afek ltd.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)
Table 2. US Lymphedema Treatment Market, by Condition Type– Revenue and Forecast to 2028 (US$ Million)
Table 3. US Lymphedema Treatment Market, by Non- Treatment Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Lymphedema Treatment Market, by Non- Treatment Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Lymphedema Treatment Market Segmentation
Figure 2. North America Lymphedema Treatment Market, By Country
Figure 3. North America Lymphedema Treatment Market Overview
Figure 4. Condition Type Segment led the Market in 2021
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints for North America Lymphedema Treatment Market
Figure 9. North America Lymphedema Treatment Market –Forecast and Analysis to 2028
Figure 10. North America Lymphedema Treatment Market, by Condition Type, 2021 & 2028 (%)
Figure 11. North America Primary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. North America Secondary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. North America Lymphedema Treatment Market, by Treatment Type 2021 & 2028 (%)
Figure 14. North America Laser Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. North America Compression Devices and Bandaging: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. North America Drug Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. North America Physiological Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. North America Lymphovenous Anastomosis (LVA): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. North America Vascularized Lymph Nodes Transfer (VLNT): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. North America Debulking Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. North America Surgical Debulking: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. North America Liposuction: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. North America Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. North America Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. North America Lymphedema Treatment Market, by End User, 2021 & 2028 (%)
Figure 26. North America Hospitals: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. North America Clinics: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. North America Clinical Research Organizations (CRO’s): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. North America Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. North America: Lymphedema Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 31. North America: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)
Figure 32. US: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Canada: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Mexico: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Impact of COVID-19 Pandemic in North American Country Markets
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For